We serve Chemical Name:2-(bromomethyl)-4-methyl-1-(trifluoromethyl)benzene CAS:886502-86-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(bromomethyl)-4-methyl-1-(trifluoromethyl)benzene
CAS.NO:886502-86-9
Synonyms:5-Methyl-2-(trifluoromethyl)benzyl bromide;JRD-1910
Molecular Formula:C9H8BrF3
Molecular Weight:253.05900
HS Code:2903999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:251.97600
LogP:3.90870
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN3265
Packing Group:III
Contact us for information like 5-Methyl-2-(trifluoromethyl)benzyl bromide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,JRD-1910 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,JRD-1910 Use and application,5-Methyl-2-(trifluoromethyl)benzyl bromide technical grade,usp/ep/jp grade.
Related News: This is how an API becomes a medicine. 2-(bromomethyl)-4-methyl-1-(trifluoromethyl)benzene manufacturer Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. 2-(bromomethyl)-4-methyl-1-(trifluoromethyl)benzene supplier Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. 2-(bromomethyl)-4-methyl-1-(trifluoromethyl)benzene vendor The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs. 2-(bromomethyl)-4-methyl-1-(trifluoromethyl)benzene factory Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.
